NR
Nagabrahmachary Ravutla
About Nagabrahmachary Ravutla
Data last updated:
Nagabrahmachary Ravutla is a Director at Medione Enterprises (Opc) Private Limited (since 2025), Director at Ravyn Life Sciences Private Limited (since 2025) and Director at Ingenix Pharma Private Limited (since 2022). The companies operate in Paper and Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medione Enterprises (Opc) Private Limited U21003TS2025OPC197516 | Director | 23 Apr 2025 | 2025 | Active | |
| Ravyn Life Sciences Private Limited U21009TS2025PTC193232 | Director | 23 Jan 2025 | 2025 | Active | |
| Ingenix Pharma Private Limited U24290TG2022PTC167835 | Director | 31 Oct 2022 | 2022 | Active |
Board colleagues of Nagabrahmachary Ravutla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajaram Mohan Nagasai Kumar Chapala | 10918895 | Ravyn Life Sciences Private Limited | Director |
| Ramakrishna Tedla | 09777348 | Ingenix Pharma Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagabrahmachary Ravutla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagabrahmachary Ravutla
Nagabrahmachary Ravutla currently holds 3 directorships: Medione Enterprises (Opc) Private Limited (Director, since 23 Apr 2025); Ravyn Life Sciences Private Limited (Director, since 23 Jan 2025); Ingenix Pharma Private Limited (Director, since 31 Oct 2022).
Nagabrahmachary Ravutla was first appointed on 31 Oct 2022 as Director at Ingenix Pharma Private Limited. The most recent appointment on record is 23 Apr 2025 at Medione Enterprises (Opc) Private Limited.
The current boards of Nagabrahmachary Ravutla's companies include Rajaram Mohan Nagasai Kumar Chapala (Ravyn Life Sciences Private Limited), Ramakrishna Tedla (Ingenix Pharma Private Limited).